Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payal Grover

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|October 3, 2013
A novel helper phage enabling construction of genome-scale ORF-enriched phage display librariesAmita Gupta, Nimisha Shrivastava, Payal Grover, et al.
Biochemical and Biophysical Research Communications|September 17, 2023
F77 antigen is a promising target for adoptive T cell therapy of prostate cancerPayal Grover, Selene Nunez-Cruz, John Leferovich, et al.
Breast Cancer (Dove Medical Press)|October 27, 2021
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer DiagnosticsJustin Lengfeld, Hongtao Zhang, Steven Stoesz, et al.
Biochemical and Biophysical Research Communications|February 15, 2023
Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancerPeeyush N Goel, Hongtao Zhang, Ramachandran Murali, et al.
Breast Cancer (Dove Medical Press)|November 4, 2024
Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor DevelopmentPeeyush N Goel, Makoto Katsumata, Wei Qian, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityOriana Y Teran Pumar, Elton L VanNoy, Abigail Haffey, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|October 3, 2013
A novel helper phage enabling construction of genome-scale ORF-enriched phage display librariesAmita Gupta, Nimisha Shrivastava, Payal Grover, et al.
Biochemical and Biophysical Research Communications|September 17, 2023
F77 antigen is a promising target for adoptive T cell therapy of prostate cancerPayal Grover, Selene Nunez-Cruz, John Leferovich, et al.
Breast Cancer (Dove Medical Press)|October 27, 2021
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer DiagnosticsJustin Lengfeld, Hongtao Zhang, Steven Stoesz, et al.
Biochemical and Biophysical Research Communications|February 15, 2023
Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancerPeeyush N Goel, Hongtao Zhang, Ramachandran Murali, et al.
Breast Cancer (Dove Medical Press)|November 4, 2024
Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor DevelopmentPeeyush N Goel, Makoto Katsumata, Wei Qian, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityOriana Y Teran Pumar, Elton L VanNoy, Abigail Haffey, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 2